Page last updated: 2024-09-04

nco 700 and gabexate

nco 700 has been researched along with gabexate in 1 studies

*Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin. [MeSH]

*Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin. [MeSH]

Compound Research Comparison

Studies
(nco 700)
Trials
(nco 700)
Recent Studies (post-2010)
(nco 700)
Studies
(gabexate)
Trials
(gabexate)
Recent Studies (post-2010) (gabexate)
150074353106

Protein Interaction Comparison

ProteinTaxonomynco 700 (IC50)gabexate (IC50)
Solute carrier family 22 member 2Homo sapiens (human)0.9
Coagulation factor XHomo sapiens (human)4.61
PlasminogenHomo sapiens (human)0.431
Urokinase-type plasminogen activatorHomo sapiens (human)0.431
Serine protease hepsinHomo sapiens (human)0.383
Multidrug and toxin extrusion protein 1Homo sapiens (human)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinoshita, H; Shibata, T; Suehiro, S; Yamamoto, F1

Other Studies

1 other study(ies) available for nco 700 and gabexate

ArticleYear
Effects of protease inhibitors on postischemic recovery of the heart.
    Cardiovascular drugs and therapy, 1997, Volume: 11, Issue:4

    Topics: Animals; Benzamidines; Creatine Kinase; Gabexate; Glycoproteins; Guanidines; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Piperazines; Protease Inhibitors; Rats; Rats, Wistar

1997